Legal & General Group’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
1,490,521
+71,927
| +5% | +$809K | ﹤0.01% | 927 |
|
|
2025
Q1 | $8.09M | Buy |
1,418,594
+567,173
| +67% | +$3.23M | ﹤0.01% | 1257 |
|
|
2024
Q4 | $8.37M | Sell |
851,421
-575,077
| -40% | -$5.65M | ﹤0.01% | 1287 |
|
|
2024
Q3 | $11.5M | Sell |
1,426,498
-25,441,422
| -95% | -$206M | ﹤0.01% | 1106 |
|
|
2024
Q2 | $8.86M | Buy |
26,867,920
+15,430,112
| +135% | +$5.09M | ﹤0.01% | 1187 |
|
|
2024
Q1 | $13.4M | Buy |
11,437,808
+9,867,029
| +628% | +$11.5M | ﹤0.01% | 998 |
|
|
2023
Q4 | $2.65M | Buy |
1,570,779
+14,829
| +1% | +$25K | ﹤0.01% | 1808 |
|
|
2023
Q3 | $2.82M | Buy |
1,555,950
+682,325
| +78% | +$1.24M | ﹤0.01% | 1741 |
|
|
2023
Q2 | $1.62M | Buy |
873,625
+127,831
| +17% | +$238K | ﹤0.01% | 2015 |
|
|
2023
Q1 | $992K | Buy |
745,794
+26,424
| +4% | +$35.1K | ﹤0.01% | 2155 |
|
|
2022
Q4 | $1.22M | Buy |
719,370
+133,033
| +23% | +$225K | ﹤0.01% | 2092 |
|
|
2022
Q3 | $1.83M | Buy |
586,337
+334,814
| +133% | +$1.04M | ﹤0.01% | 1899 |
|
|
2022
Q2 | $599K | Buy |
+251,523
| New | +$599K | ﹤0.01% | 2302 |
|